Mayo Clinic cardiologist on identifying risks of hydroxychloroquine for coronavirus treatment
Share

Mayo Clinic cardiologist on identifying risks of hydroxychloroquine for coronavirus treatment

The FDA is warning against the use of hydroxychloroquine for the treatment of Covid-19. This follows the release of study results published in the Journal of the American Medical Association that showed some Covid-19 patients treated with the drug developed irregular heartbeats. Dr. Michael Ackerman, cardiologist at the Mayo Clinic, joins "Squawk Box" to discuss.
07:33
Mon, Apr 27 20208:51 AM EDT